140 related articles for article (PubMed ID: 37390712)
1. Erythropoietin-mediated IL-17 F attenuates sepsis-induced gut microbiota dysbiosis and barrier dysfunction.
Ling H; Lin Y; Bao W; Xu N; Chen L; Zhao L; Liu C; Shen Y; Zhang D; Gong Y; Gao Q; Wang J; Jin S
Biomed Pharmacother; 2023 Sep; 165():115072. PubMed ID: 37390712
[TBL] [Abstract][Full Text] [Related]
2. Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis.
Gai X; Wang H; Li Y; Zhao H; He C; Wang Z; Zhao H
Front Cell Infect Microbiol; 2021; 11():736204. PubMed ID: 34631604
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.
Wei Y; Yang J; Wang J; Yang Y; Huang J; Gong H; Cui H; Chen D
Crit Care; 2016 Oct; 20(1):332. PubMed ID: 27751177
[TBL] [Abstract][Full Text] [Related]
4. Indole-3-Propionic Acid as a Potential Therapeutic Agent for Sepsis-Induced Gut Microbiota Disturbance.
Fang H; Fang M; Wang Y; Zhang H; Li J; Chen J; Wu Q; He L; Xu J; Deng J; Liu M; Deng Y; Chen C
Microbiol Spectr; 2022 Jun; 10(3):e0012522. PubMed ID: 35658593
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota.
He S; Cui S; Song W; Jiang Y; Chen H; Liao D; Lu X; Li J; Chen X; Peng L
mBio; 2022 Apr; 13(2):e0368821. PubMed ID: 35266816
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances.
Lou X; Xue J; Shao R; Yang Y; Ning D; Mo C; Wang F; Chen G
Front Immunol; 2022; 13():1063543. PubMed ID: 36713461
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
8. Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice.
Fang H; Wang Y; Deng J; Zhang H; Wu Q; He L; Xu J; Shao X; Ouyang X; He Z; Zhou Q; Wang H; Deng Y; Chen C
mSystems; 2022 Jun; 7(3):e0139921. PubMed ID: 35642838
[TBL] [Abstract][Full Text] [Related]
9. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
10. [Fecal microbiota transplantation regulates the cholinergic anti-inflammatory pathway in cerebral cortex of septic rats through intestinal microbiota].
Li S; Xu N; Hua R; Niu X; Lyu C; Li M; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1102-1107. PubMed ID: 31657333
[TBL] [Abstract][Full Text] [Related]
11. Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Lin X; Liu Y; Ma L; Ma X; Shen L; Ma X; Chen Z; Chen H; Li D; Su Z; Chen X
J Transl Med; 2021 Jul; 19(1):317. PubMed ID: 34301274
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice.
Zhu X; Zhao L; Lei L; Zhu Y; Xu J; Liu L
Microbiol Res; 2024 May; 282():127654. PubMed ID: 38417203
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation and Hydrocortisone Ameliorate Intestinal Barrier Dysfunction and Improve Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis.
Assimakopoulos SF; Papadopoulou I; Bantouna D; de Lastic AL; Rodi M; Mouzaki A; Gogos CA; Zolota V; Maroulis I
Shock; 2021 May; 55(5):666-675. PubMed ID: 32496421
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
15. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
[TBL] [Abstract][Full Text] [Related]
16. Lacticaseibacillus rhamnosus TR08 alleviated intestinal injury and modulated microbiota dysbiosis in septic mice.
Yin J; Sun W; Yu X; Xiao X; Li B; Tong Z; Ke L; Mao W; Li W
BMC Microbiol; 2021 Sep; 21(1):249. PubMed ID: 34536996
[TBL] [Abstract][Full Text] [Related]
17. Enteric dysbiosis is associated with sepsis in patients.
Liu Z; Li N; Fang H; Chen X; Guo Y; Gong S; Niu M; Zhou H; Jiang Y; Chang P; Chen P
FASEB J; 2019 Nov; 33(11):12299-12310. PubMed ID: 31465241
[TBL] [Abstract][Full Text] [Related]
18. Metformin attenuated sepsis-related liver injury by modulating gut microbiota.
Liang H; Song H; Zhang X; Song G; Wang Y; Ding X; Duan X; Li L; Sun T; Kan Q
Emerg Microbes Infect; 2022 Dec; 11(1):815-828. PubMed ID: 35191819
[TBL] [Abstract][Full Text] [Related]
19. Gut dysbiosis correction contributes to the hepatoprotective effects of
Yan X; Wang Y; Ren XY; Liu XY; Ma JM; Song RL; Wang XH; Dong Y; Yu AX; Fan QQ; Wei J; She GM
Food Funct; 2021 Oct; 12(20):10281-10290. PubMed ID: 34549762
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.
Zhu Y; He C; Li X; Cai Y; Hu J; Liao Y; Zhao J; Xia L; He W; Liu L; Luo C; Shu X; Cai Q; Chen Y; Lu N
J Gastroenterol; 2019 Apr; 54(4):347-358. PubMed ID: 30519748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
